We have isolated and sequenced several cDNAs derived from the sea squirt Ciona intestinalis that encode vitamin K-dependent proteins. Four of these encode ␥-carboxyglutamic acid (Gla) domain-containing proteins, which we have named Ci-Gla1 through Ci-Gla4. Two additional cDNAs encode the apparent orthologs of ␥-glutamyl carboxylase and vitamin K epoxide reductase. Ci-Gla1 undergoes ␥-glutamyl carboxylation when expressed in CHO cells and is homologous to Gla-RTK, a putative receptor tyrosine kinase previously identified in a related ascidian. The remaining three Gla domain proteins are similar to proteins that participate in fundamental developmental processes, complement regulation, and blood coagulation. These proteins are generally expressed at low levels throughout development and exhibit either relatively constant expression (Ci-Gla1, ␥-glutamyl carboxylase, and vitamin K epoxide reductase) or spatiotemporal regulation (Ci-Gla2, -3, and -4). These results demonstrate the evolutionary emergence of the vitamin K-dependent Gla domain before the divergence of vertebrates and urochordates and suggest novel functions for Gla domain proteins distinct from their roles in vertebrate hemostasis. In addition, these findings highlight the usefulness of C. intestinalis as a model organism for investigating vitamin K-dependent physiological phenomena, which may be conserved among the chordate subphyla.
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ascidian ͉ ␥-carboxyglutamic acid ͉ urochordate ͉ warfarin V itamin K is an essential cofactor in the conversion of glutamic acid residues to ␥-carboxylglutamic acid (Gla) residues (1) . This posttranslational modification is carried out within the endoplasmic reticulum by the concerted action of two membrane-associated enzymes, ␥-glutamyl carboxylase (GGC) and vitamin K epoxide reductase (VKOR) (2, 3) . In vertebrates, GGC selects protein substrates containing a propeptide that, in most cases, is proteolytically removed after glutamyl carboxylation (4) .
Most vertebrate Gla proteins have a characteristic Gla domain, a highly conserved sequence of Ϸ40 residues that contains between 7 and 13 Gla residues. After glutamyl carboxylation, the coordination of calcium ions by Gla side chains promotes a conformational change that allows the Gla domain to perform its essential physiological function, namely binding to phospholipid surfaces that contain phosphatidylserine (5) . This anionic aminophospholipid is ordinarily restricted to the inner leaflet of the plasma membrane under normal cellular homeostasis but is exposed extracellularly in response to calcium mobilizing signals, notably during platelet activation (6) . In this manner, vitamin K-dependent procoagulant and anticoagulant proteins are directed from the fluid phase to a two-dimensional surface at the site of vascular injury. This essential function of the clotting factors is impaired by the anticoagulant warfarin, an antagonist of VKOR that blocks the regeneration of vitamin K after glutamyl carboxylation.
Several lines of evidence now implicate Gla domain proteins in physiological processes distinct from blood coagulation. For example, protein S was first characterized as an anticoagulant cofactor. However, the majority of circulating protein S is bound to the complement regulator C4b-binding protein (7) . This protein complex lacks the anticoagulant activity of free protein S but negatively regulates complement on the surface of apoptotic cells, the binding to which depends upon the Gla domain of protein S (8, 9) . In addition, both protein S and its homolog Gas6 activate certain members of the Axl subfamily of receptor tyrosine kinases to transduce antiapoptotic and proliferative signals (10) . In the case of Gas6, many of the functions ascribed to the molecule are abrogated when it is produced in the presence of warfarin, underscoring the essential nature of ␥-glutamyl carboxylation (11) (12) (13) .
The transmembrane Gla proteins are the most recently identified vertebrate vitamin K-dependent proteins. Members of this protein family include proline-rich Gla proteins 1 (PRGP1) and 2 (PRGP2; ref. 14) and transmembrane Gla proteins 3 and 4 (15) and are characterized by an N-terminal extracellular Gla domain, a single-pass transmembrane region, and a C-terminal cytoplasmic region. The cytoplasmic region contains PY motifs, short peptidyl sequences that have been shown to mediate association with a variety of WW domain-containing proteins (16) . Collectively, these features suggest a role in signal transduction, possibly in response to extracellular phosphatidylserine exposure. Interestingly, an apparent ortholog of PRGP1 has been identified in Xenopus oocytes and has been shown to undergo regulated phosphorylation in response to cell-cycle progression (17) .
The ability to posttranslationally convert Glu residues to Gla residues is not restricted to deuterostome animals (18) . Gene and cDNA sequences that encode GGC orthologs have been identified in diverse protostomes, including cone snails of the genus Conus (19) and arthropods, such as Drosophila melanogaster (20) . A variety of Gla-containing neuroactive peptides have been isolated from cone snail venom (ref. 21 and refs. therein) and represent the only currently known GGC substrates in protostomes. These peptides, however, exhibit no discernible sequence similarity to the Gla domains found in vertebrates. Moreover, sequence paralogs of vertebrate Gla domains do not appear to be present in the Drosophila genome (20) . Although Gla-containing polypeptides are thus likely to be ubiquitous among metazoans, the Gla domain, with its canonical fingerprint of Gla residues and characteristic phosphatidylserine-binding properties, has been definitively identified only in vertebrate species.
The vertebrate origin of the Gla domain, however, has been challenged by recent reports indicating the presence of Gla domain proteins in ascidians, marine invertebrates of the chor- date subphylum Urochordata (22, 23) . The identification of ascidian Gla domain proteins is significant for several reasons. First, despite having certain developmental features in common with vertebrates, ascidians differ notably from vertebrates in that they lack a blood coagulation cascade (24) . Therefore, ascidian Gla domain proteins are involved in physiological processes other than hemostatic coagulation. Second, the presence of Gla domain proteins in extant urochordates implies that the Gla domain emerged in an ancestor common to vertebrates and urochordates. The evolutionary emergence of urochordates predates that of vertebrates, and hence the development of the blood coagulation cascade, by tens of millions of years. The Gla domain must therefore have served a more ancestral function and was only later adapted to perform its essential role in vertebrate hemostasis. Finally, the vertebrate coagulation cascade owes its complexity, in large part, to both individual gene and whole-genome duplications, most of which antedate the urochordate-vertebrate split. We have undertaken the current investigation in an effort to understand how an ancestral nonduplicated protochordate genome may have given rise to the progenitors of the vertebrate vitamin K-dependent coagulation factors.
Results

Evidence of Gla Domain Proteins in Ciona intestinalis and Ciona
savignyi. Our analyses of the C. intestinalis genome database (25) , the C. intestinalis EST database (26) , and the genome database of a related ascidian, C. savignyi, indicated that exactly four Gla domain sequences are present in these species (Fig. 1) . We named these sequences Gla1 through Gla4 and denoted the species by prefix [C. intestinalis (Ci) or C. savignyi (Cs)]. These sequences aligned well with those of human Gla domain proteins, displaying similarity within the predicted propeptide region as well as conservation of key glutamate and cysteine residues within the Gla domain. Both Ci-Gla1 and Cs-Gla1 lacked a discernible signal peptide and aligned most closely with Gla-RTK, a receptor tyrosine kinase from the ascidian Halocynthia roretzi (23) . The presence of four potential Gla domainencoding sequences within the C. intestinalis genome has also been reported as part of an in silico analysis of the protein domains involved in vertebrate blood coagulation and fibrinolysis (22) .
Full-Length Sequences of C. intestinalis Gla Domain Proteins.
We identified candidate sequences predicted to encompass the entire coding regions of the four Gla domain proteins and amplified these sequences from juvenile C. intestinalis cDNA by PCR. A schematic depiction of the predicted protein sequences ( Fig. 2) illustrates variations in modular architecture, topology, and size. The nucleotide sequences of these cDNAs and their conceptual translations were deposited in the GenBank database with the following accession nos.: DQ900931 (Ci-Gla1), DQ900933 (Ci-Gla2), DQ900934, DQ900935 and DQ900936 (Ci-Gla3), and DQ900937 (Ci-Gla4).
Ci-Gla1 is predicted to be a single-pass transmembrane protein. However, unlike the vertebrate transmembrane Gla proteins, Ci-Gla1 lacks cytoplasmic PY motifs. Rather, Ci-Gla1 is structurally homologous to H. roretzi Gla-RTK over its entire length, comprising a propeptide, a Gla domain, a single-pass transmembrane region, and a receptor tyrosine kinase domain. The tyrosine kinase domain of Ci-Gla1 aligns closely with those of several human receptor tyrosine kinases, particularly within well characterized regions involved in ATP-binding, activation, and catalysis (Fig. 6 , which is published as supporting information on the PNAS web site). Sequence comparison of full-length Ci-Gla1 with a wide variety of vertebrate receptor tyrosine kinases (Fig. 7 , which is published as supporting information on the PNAS web site) indicates that Ci-Gla1 closely resembles Met and Ron, protooncogene products that are the receptors for hepatocyte growth factor and macrophage stimulating protein, respectively.
Ci-Gla2 is structurally similar to vertebrate Jagged 1 and 2, integral membrane proteins that serve as ligands for members of the Notch family of receptors. The Notch͞Jagged signaling axis is critical for cell-fate decisions that govern the development of the vertebrate body plan and is homologous to the lessredundant Notch and Lin12 signaling pathways of Drosophila and Caenorhabditis elegans, respectively. Features of Ci-Gla2 that resemble those of Jagged proteins include a signal peptide, a Delta͞Serrate͞Lag2 (DSL) domain near the N terminus, multiple tandem EGF domains, and a single transmembrane region. Unexpectedly, in contrast to other known Gla domain proteins, in which the propeptide and Gla domain are located at the N terminus of the proprotein, the propeptide and Gla domain of Ci-Gla2 are located between the DSL domain and the first EGF domain, Ϸ100 residues from the N terminus. Such an arrangement raises the possibility that GGC can both recognize internal propeptides and carboxylate glutamyl residues at locations other than the N terminus of target proteins. In both Ci-Gla2 and Cs-Gla2, basic residues are conserved at positions within their propeptides that are analogous to the Arg(-4)-Arg͞ Lys(-2)-Arg(-1) propeptide cleavage site found in the vitamin Fig. 1 . Alignment of putative Gla domain proteins from C. intestinalis (Ci) and C. savignyi (Cs) with a Gla domain receptor tyrosine kinase from H. roretzi (Gla-RTK) and human coagulation factor IX, PRGP1, Gas6, and prothrombin. Signal peptides predicted by SignalP (51) are hightlighted in blue. Positions of glutamate residues that are likely to undergo posttranslational conversion to ␥-carboxyglutamate are denoted with red shading. Strictly conserved cysteine residues are shown in yellow, and an intrachain disulfide bond is indicated with a solid line. Other highly conserved residues are shaded with gray. The positions of key residues within the propeptide that contribute to recognition by GGC (52, 53) are indicated with asterisks. The location of the propeptidase cleavage site within the vitamin K-dependent clotting factors is indicated with a green wedge.
K-dependent clotting factors (Fig. 1) , suggesting that proteolytic removal of the Ϸ200 residue N-terminal region, which encompasses the DSL domain and propeptide, may be important for the function of these proteins.
Ci-Gla3 has a relatively simple modular structure, consisting of a signal peptide, propeptide, and Gla domain, followed by either two, four, or six tandem EGF domains. Three different variant cDNAs (Ci-Gla3A, -B, and -C) were isolated by PCR in approximately equal abundance. Alignment of these sequences with C. intestinalis genomic DNA confirmed that these three variants arise from differential RNA splicing such that Ci-Gla3B lacks EGF domains 2 and 3 of Ci-Gla3A, and Ci-Gla3C lacks EGF domains 2-5 of CiGla3A. Although Ci-Gla3 lacks a serine protease domain, it is most similar to the Gla domain-and EGF domain-containing serine proteases (protein C and factors VII, IX, and X), in that its propeptide and Gla domain are preceded only by a signal peptide and immediately followed by EGF domains without any intervening sequence.
Ci-Gla4 resembles an elongated version of the Protein S͞Gas6 prototype. The Gla domain of Ci-Gla4 is separated from the first EGF domain by a short putative disulfide loop that occupies a position analogous to the proteolytically sensitive loop of Protein S (27, 28) , as well as to a disulfide loop in Gas6 that is not known to be cleaved by proteases. The common evolutionary origin of Ci-Gla4, Protein S, and Gas6 is further suggested by the observation that this disulfide loop is encoded by a single exon for all three proteins. The central region of Ci-Gla4 consists of 17 tandem EGF domains and is followed by two laminin G-like modules analogous to those that constitute the sex hormonebinding globulin-like region at the C termini of both Protein S and Gas6.
␥-Glutamyl Carboxlyation of Ci-Gla1. A previous report demonstrated that the isolated propeptide of H. roretzi Gla-RTK is capable of stimulating glutamyl carboxylation of a synthetic peptide by recombinant human GGC (23) . We have extended this analysis by the heterologous expression of full-length CiGla1 in CHO cells, which are capable of carrying out ␥-glutamyl carboxylation (29) . The Ci-Gla1 cDNA was inserted into plasmid pCBio, a vector designed for the doxycycline-inducible expression of proteins bearing a C-terminal biotin acceptor peptide.
CHO-K1 cells engineered to express a tetracycline-regulated transcriptional transactivator (CHO-K1 Tet-On cells) were transfected with this construct, and expression was analyzed by Western blot (Fig. 3) . Bands corresponding to the predicted molecular weight of Ci-Gla1 (65 kDa) were detected with streptavidin, regardless of whether cells were cultured in the presence of warfarin or vitamin K. Development of the blot with a monoclonal antibody specific for Gla residues (30) demonstrated that ␥-glutamyl carboxylation of Ci-Gla1 occurred in the presence of vitamin K but was abrogated by warfarin.
Isolation of Ci-GGC and Ci-VKOR cDNAs.
The glutamyl carboxylation of Ci-Gla1 heterologously expressed in mammalian cells implies that the carboxylation machinery of ascidians more closely resembles that of vertebrates than it does that of protostome invertebrates, such as arthropods and mollusks.
To test this hypothesis, we amplified cDNAs predicted to encode GGC and VKOR from juvenile C. intestinalis cDNA by PCR. An alignment of the sequence of Ci-GGC (GenBank accession no. DQ900938) with GGC sequences from a variety of vertebrate and invertebrate species (Fig. 8 , which is published as supporting information on the PNAS web site) showed a high degree of conservation within, although not restricted to, the five established membrane-spanning regions (31), a previously identified GGC ''fingerprint'' region (32) , and an internal propeptide-like sequence that is implicated in recognition of the substrate propeptide (33) . Pairwise sequence comparisons (Fig.  9 , which is published as supporting information on the PNAS web site) revealed a moderately higher degree of sequence identity between Ci-GGC and vertebrate GGCs than between Ci-GGC and invertebrate GGCs. For example, sequence identity between Ci-GGC and human GGC was 48%, as compared with 43% for cone snail (Conus textile) GGC and 40% for Drosophila GGC. However, this range of sequence identity was comparable to that between human GGC and cone snail GGC (49%), indicating pronounced GGC sequence divergence between vertebrates and urochordates on the order of that observed between vertebrates and protostome invertebrates.
We amplified and sequenced a cDNA predicted to encode the ortholog of VKOR, a key enzyme involved in regenerating vitamin K and the pharmacological target of warfarin-type anticoagulants. An alignment of the Ci-VKOR sequence (GenBank accession no. DQ900932) illustrates a moderate degree of identity with vertebrate VKOR sequences (Fig. 10 , which is published as supporting information on the PNAS web site) that ranges from 41% (human VKOR) to 46% (zebrafish VKOR). Notably, residues corresponding to Val-29, Arg-58, and Leu-128 of human VKOR, mutations of which are associated with resistance to warfarin-type anticoagulants (34) , are conserved in C. intestinalis VKOR.
Analysis of Developmental Expression Patterns by Quantitative PCR (qPCR).
The expression levels of Ci-Gla1 through Ci-Gla4, Ci-GGC, and Ci-VKOR were evaluated by qPCR by using template cDNA derived from four different developmental time points: egg, larva, juvenile, and adult (Fig. 4) . Because no single gene has yet been identified in ascidians that exhibits constant expression throughout these phases of development, we determined the expression levels of four genes commonly used as controls in other systems: beta actin, calreticulin, rho GDP dissociation inhibitor (RhoGDI), and E1 ubiquitin-activating enzyme (Ube1). In general, expression of Gla domain protein genes was low throughout development, at levels comparable with or less than that of the lowest expressing control gene, Ci-Ube1. CiGla1, Ci-GGC, and Ci-VKOR were expressed at relatively constant levels from egg to adult. In contrast, expression of Ci-Gla2, -3, and -4 was not detected in the egg but appeared at the larval stage and, in the case of Ci-Gla3, persisted through the adult stage.
Whole-Mount in Situ Hybridization. Of the genes identified in this study, interesting patterns of hybridization signals on wholemount specimens were detected for Ci-Gla3 and -4 (Fig. 5) . In tailbud embryos, Ci-Gla3 is selectively expressed in the tail in a pattern that closely resembles that of Ci-Mox (35), a member of the extended homeobox gene cluster implicated in vertebrate mesoderm regionalization and differentiation (36, 37) . In the juvenile, Ci-Gla3 is expressed predominantly in the stomach, with a lower level of expression seen in hemocytes and in the endostyle, an organ that is homologous to the vertebrate thyroid.
Ci-Gla4 is expressed in two discrete domains within the CNS of the tailbud embryo. Of these, the anterior expression domain (Fig. 5C, arrow 1) roughly corresponds to the anterior region of the zone demarcated by Ci-Otx, an established marker for the region of the larval ascidian CNS that is homologous to the vertebrate forebrain and͞or midbrain (38, 39) . The second Ci-Gla4 expression domain (Fig. 5C, arrow 2) corresponds to a region of the CNS that is homologous to the vertebrate anterior hindbrain and͞or the midbrain-hindbrain boundary, an area of the tailbud embryo that is characterized by the expression of engrailed (Ci-En) and a homolog of vertebrate fibroblast growth factors 8, 17, and 18 (Ci-FGF8͞17͞18; refs. 39 and 40). Ci-Gla4 is only minimally expressed in the juvenile, exhibiting very light staining of the stomach and hemocytes.
Discussion
The presence of Gla domain proteins in urochordates such as C. intestinalis clearly places the evolutionary appearance of this vitamin K-dependent protein module well before the emergence of the blood coagulation cascade, which is widely assumed to have been a vertebrate invention. Although the functional characterization of the ascidian Gla domain proteins will require additional experimentation, a few plausible hypotheses can be made on the basis of sequence data. First, the transmembrane topologies of Ci-Gla1 and -2 suggest a role for these proteins in transduction of extracellular signals. Such signals may be either autocrine or paracrine in nature but are likely to be initiated by the extracellular presentation of phosphatidylserine-containing membrane surfaces. Second, the similarity between the modular structures of Ci-Gla4, protein S, and Gas6 implies a common mode of action. Protein S and Gas6 are well characterized as ligands for members of the Axl family of receptor tyrosine kinases, a single ortholog of which is present in the C. intestinalis genome (Fig. 7) . Although it is not known whether Ci-Gla4 is the actual ligand for this receptor, the identification of a potential Axl signaling axis in ascidians is consistent with the view that the function of protein S as a negative coregulator of the blood coagulation cascade is a relatively recent adaptation that antedates its more ancestral function as a ligand for receptor tyrosine kinases of the Axl subfamily.
The conspicuous absence of serine proteases among the ascidian Gla domain proteins is also notable. Interestingly, a 39-kDa serine protease with certain thrombin-like attributes was identified in ascidian hemolymph (41) , although based on our findings, it would not be expected to have a Gla domain. The physical linkage of a Gla domain and a serine protease domain is a common feature of the vertebrate coagulation factors that serves to direct specific proteolytic activities from a mobile fluid phase to a stationary procoagulant surface. Thus, although the Gla domain may no longer be considered unique to vertebrates, the linkage of the Gla domain to a protease may very well be a vertebrate innovation that is ideally suited for hemostasis in the relatively high-flow high-pressure vertebrate vasculature.
Several hypotheses have been proposed to explain the complexity of the proteolytic component of the clotting cascade, most of which rely on the assumption that prothrombin emerged first. This idea is consistent with genetic analyses indicating that (pro)thrombin belongs to a class of serine proteases that is older than that of the other Gla domain-containing proteases (42) . Such a rudimentary system could then have acquired regulatory complexity as well as the potential for rapid spatially restricted amplification by addition of upstream Gla domain-and EGF domain-containing proteases (factors VII, IX, and X). These proteases are likely to have arisen from a prototypical Gla-EGF 2 -serine protease structure through successive gene and͞or global genome duplications (43, 44) .
In a recent report comparing the puffer fish and ascidian genomes, Jiang and Doolittle (22) have proposed that the Gla-EGF 2 -serine protease prototype evolved directly from prothrombin by the exchange of the two prothrombin kringle domains with two EGF domains. Our findings, however, suggest an alternative model in which the Gla-EGF 2 -serine protease prototype arose independently of prothrombin. In contrast to the Gla-EGF 2 -serine proteases, prothrombin has a short disulfide loop that intervenes between the Gla domain and its first kringle domain, an arrangement that is found in Ci-Gla4, as well as in protein S and Gas6. A single transposition between a kringle-containing protease and a Ci-Gla4-like molecule could therefore have generated the Glaloop-kringle 2 -serine protease prothrombin prototype. The Gla-EGF 2 -serine proteases, however, lack this disulfide loop and are therefore more structurally analogous to the Gla-EGF (2) (3) (4) (5) (6) pattern seen in Ci-Gla3. We propose that a single transposition between a Ci-Gla3-like molecule and a serine protease, given its relative parsimony, is more likely to have been the mode by which the Gla-EGF 2 -serine protease prototype was generated.
Materials and Methods
Database Search and Analysis. The Kyoto University C. intestinalis EST (Ghost) Database (26) was searched by using TBLASTN (45) with query sequences derived from the human Gla domain protein PRGP2 (GenBank accession no. O14669), human VKOR (GenBank accession no. AAR82914) and human GGC (GenBank accession no. AAA58643). Contiguous cDNA sequences were assembled from ESTs by using the CAP sequence assembly program (46) and used to search the U.S. Department of Energy Joint Genome Institute C. intestinalis genome database (25) . The Ghost database was iteratively queried with candidate genomic sequences to identify plausible protein encoding regions within genomic scaffolds. The resulting sequences were analyzed for probable intron͞exon boundaries with FGENESH (Softberry, Mount Kisco, NY). The Broad Institute C. savignyi genome database (publicly accessible on the National Center for Biotechnology Information web site) was searched by using TBLASTN with conceptual translations of candidate C. intestinalis genomic sequences to identify orthologous Gla domain encoding sequences in C. savignyi.
cDNA Cloning. Oligonucleotide PCR primers pairs were designed based on FGENESH output sequences. Juvenile C. intestinalis cDNA was prepared as described (47) . cDNA sequences were amplified from juvenile cDNA by PCR with Advantage 2 Polymerase (Clontech, Mountain View, CA) using reaction conditions recommended by the manufacturer. The nucleotide sequences of the PCR primers used are listed in Table 1 , which is published as supporting information on the PNAS web site. Amplimers were ligated directly into pCR2.1-TOPO (Invitrogen, Carlsbad, CA), and at least 12 individual clones of each cDNA were sequenced on an ABI 3730XL DNA Analyzer by using BigDye v3.1 sequencing reagent (Applied Biosystems, Foster City, CA).
Detection of Gla in Recombinant Ci-Gla1. The expression of recombinant Ci-Gla1 in mammalian cells and the immunological analysis of its Gla content are described in detail in Supporting Text, which is published as supporting information on the PNAS web site. Briefly, the Ci-Gla1 coding sequence was ligated into plasmid pCBio (GenBank accession no. DQ520291), a mammalian expression vector engineered for the site-specific biotinylation of target proteins (unpublished work). Protein expression was induced with doxycycline for 24 h in CHO Tet-On cells (Clontech) that had been transiently transfected with expression constructs. Cell lysates were prepared 24 h posttransfection, resolved on a 4-20% Tris-glycine gel (Invitrogen), and transferred to a PVDF membrane. Total Ci-Gla1 was detected with
